Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-03-01

Clinical Trial Update: Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache [Phase 1, Phase 2]

View source ↗

Summary

The document outlines a randomized Phase 1/2 trial comparing octreotide with prochlorperazine (Compazine) for emergency department treatment of migraine headach…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Compazine (Prochlorperazine)
  • Sandostatin (Octreotide acetate)

Snippet

Sponsor: C.R.Darnall Army Medical Center | Conditions: Migraine Headache | Phase 1, Phase 2 | Status: UNKNOWN